MICHAEL F. DEMANE - 31 Mar 2022 Form 4 Insider Report for NEVRO CORP

Role
Director
Signature
/s/ Kashif Rashid, as Attorney-in-Fact for Michael DeMane
Issuer symbol
N/A
Transactions as of
31 Mar 2022
Net transactions value
$0
Form type
4
Filing time
04 Apr 2022, 21:46:12 UTC
Previous filing
04 Jan 2022
Next filing
27 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVRO Common Stock Award $0 +362 +0.91% $0.000000 40,147 31 Mar 2022 Direct F1, F2
holding NVRO Common Stock 148,775 31 Mar 2022 See footnote F3
holding NVRO Common Stock 71,986 31 Mar 2022 See footnote F4
holding NVRO Common Stock 11,600 31 Mar 2022 See footnote F5
holding NVRO Common Stock 47,980 31 Mar 2022 See footnote F6
holding NVRO Common Stock 49,911 31 Mar 2022 See footnote F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested restricted stock. The restricted stock represent quarterly retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash.
F2 Includes 1,167 restricted stock units.
F3 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
F4 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017.
F5 Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011.
F6 Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 04/23/2021.
F7 Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021.